Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Novobiocin |
| Synonyms | |
| Therapy Description |
Novobiocin binds to and inhibits HSP90, resulting in degradation of HSP90 client proteins (PMID: 10945979). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Novobiocin | Albamix | Antibiotic Pa-93 | HSP90 Inhibitor 35 | Novobiocin binds to and inhibits HSP90, resulting in degradation of HSP90 client proteins (PMID: 10945979). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05687110 | Phase I | Novobiocin | Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes | Recruiting | USA | CAN | 0 |